Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial.
作者信息
Cannon Christopher P, Perkovic Vlado, Agarwal Rajiv, Baldassarre James, Bakris George, Charytan David M, de Zeeuw Dick, Edwards Robert, Greene Tom, Heerspink Hiddo J L, Jardine Meg J, Levin Adeera, Li Jing-Wei, Neal Bruce, Pollock Carol, Wheeler David C, Zhang Hong, Zinman Bernard, Mahaffey Kenneth W
机构信息
Cardiovascular Division, Brigham & Women's Hospital and Baim Institute for Clinical Research, Boston, MA (C.P.C.).
The George Institute for Global Health, UNSW Sydney, Australia (V.P., H.J.L.H, M.J.J., J.-W.L., B.N.).
出版信息
Circulation. 2020 Feb 4;141(5):407-410. doi: 10.1161/CIRCULATIONAHA.119.044359. Epub 2019 Nov 11.
Abstract
摘要
Zotero 插件